Cardiovascular
Read More about this categoryShow Less
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.
Research Areas
- Acute Phase Reactants(15)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(88)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(124)
- Coronary Artery Disease(7)
- Diabetic Nephropathy(8)
- Endothelium(33)
- Erythrocytes & Hemoglobin(49)
- Heart Failure(33)
- Hypertension(162)
- Hypotension(24)
- Lipoproteins(61)
- Myocardial Contractility(33)
- Myocardial Hypertrophy(21)
- Myocardial Infarction(61)
- Others(1)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(48)
- Thrombosis(52)
- Vasoconstriction(59)
- Vasodilation(141)
- Cardiomyopathy(5)
- Cholesterol Metabolism(44)
Products Related to Cardiovascular(821)
- GC49682Dabigatran-d3CAS: 1246817-44-6Purity: >99.00%
An internal standard for the quantification of dabigatran
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9Purity: >95.00%
A potential impurity found in commercial preparations of vardenafil
- GC49684Dabigatran-13C-d3CAS: 2967480-55-1Purity: >99.00%
An internal standard for the quantification of dabigatran
- GC49690(3R,5R)-Rosuvastatin (calcium salt)CAS: 1422515-55-6Purity: >95.00%
A potential impurity found in bulk preparations of rosuvastatin
- GC49770Stearic Acid glycidyl ester-d5CAS: 1346598-19-3Purity: >99.00%
An internal standard for the quantification of stearic acid glycidyl ester
- GC49836BenoxaprofenCAS: 51234-28-7Purity: >98.00%
Benoxaprofen (LRCL 3794) ist eine starke und lang wirkende entzÜndungshemmende und fiebersenkende Verbindung.
- GC49882Hemokinin 1 (human) (trifluoroacetate salt)Purity: >98.00%
A peptide agonist of NK 1 receptors
- GC49884Trigonelline-d3 (chloride)Purity: >99.00%
An internal standard for the quantification of trigonelline
- GC49890β-Glycerophosphate-d5 (sodium salt hydrate)Purity: >99.00%
An internal standard for the quantification of β-glycerophosphate
- GC49916Lys-(Des-Arg9, Leu8)-Bradykinin (trifluoroacetate salt)Purity: >95.00%
A bradykinin B 1 receptor antagonist
- GC50009LY 294002 hydrochlorideCAS: 934389-88-5Purity: >98.00%
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49682 | Dabigatran-d3 | 1246817-44-6 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC49684 | Dabigatran-13C-d3 | 2967480-55-1 | >99.00% | |
An internal standard for the quantification of dabigatran | ||||
| GC49690 | (3R,5R)-Rosuvastatin (calcium salt) | 1422515-55-6 | >95.00% | |
A potential impurity found in bulk preparations of rosuvastatin | ||||
| GC49706 | Cerberin | 25633-33-4 | >98.00% | |
Cerberin is a kind of cardiac glycosides, which was found in Cerbera odollam . | ||||
| GC49733 | 1-Stearoyl-2-eicosapentaenoyl-sn-glycero-3-PC | 99264-98-9 | >95.00% | |
A phospholipid | ||||
| GC49738 | Lipid 29 | 2244716-55-8 | >98.00% | |
An ionizable amino lipid | ||||
| GC49762 | Etiocholanedione | 1229-12-5 | >98.00% | |
A neurosteroid | ||||
| GC49770 | Stearic Acid glycidyl ester-d5 | 1346598-19-3 | >99.00% | |
An internal standard for the quantification of stearic acid glycidyl ester | ||||
| GC49777 | Valsartan Acid | 164265-78-5 | >95.00% | |
A valsartan transformation product | ||||
| GC49784 | AZD 2716 | 1845753-81-2 | >98.00% | |
An sPLA 2 inhibitor | ||||
| GC49812 | Urobilin (hydrochloride) | 28925-89-5 | - | |
A byproduct of hemoglobin degradation | ||||
| GC49836 | Benoxaprofen | 51234-28-7 | >98.00% | |
Benoxaprofen (LRCL 3794) ist eine starke und lang wirkende entzÜndungshemmende und fiebersenkende Verbindung. | ||||
| GC49842 | Digoxigenin Bisdigitoxoside | 5297-05-2 | >98.00% | |
A Na + /K + -ATPase inhibitor | ||||
| GC49863 | Cytarabine 5′-monophosphate | 7075-11-8 | >95.00% | |
An active metabolite of cytarabine | ||||
| GC49866 | Desmethyl Carvedilol | 72956-44-6 | >90.00% | |
An active metabolite of carvedilol | ||||
| GC49873 | Protectin D1 methyl ester | 934005-36-4 | >95.00% | |
An esterified form of protectin D1 | ||||
| GC49880 | Bradykinin (trifluoroacetate salt) | - | >95.00% | |
An endogenous vasodilator | ||||
| GC49882 | Hemokinin 1 (human) (trifluoroacetate salt) | - | >98.00% | |
A peptide agonist of NK 1 receptors | ||||
| GC49884 | Trigonelline-d3 (chloride) | - | >99.00% | |
An internal standard for the quantification of trigonelline | ||||
| GC49885 | BQ-3020 (trifluoroacetate salt) | - | >90.00% | |
A peptide ET B receptor antagonist | ||||
| GC49890 | β-Glycerophosphate-d5 (sodium salt hydrate) | - | >99.00% | |
An internal standard for the quantification of β-glycerophosphate | ||||
| GC49916 | Lys-(Des-Arg9, Leu8)-Bradykinin (trifluoroacetate salt) | - | >95.00% | |
A bradykinin B 1 receptor antagonist | ||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | >98.00% | |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | ||||